With industry waiting on the FDA to issue regs for CBD products, the agency instead released a statement explaining why it has not yet done so—including fears that the trendy cannabinoid may cause liver damage. But advocates charge that the claim is based on faulty research.
Recent comments
3 weeks 3 days ago
4 weeks 4 days ago
4 weeks 4 days ago
5 weeks 6 days ago
11 weeks 20 hours ago
13 weeks 3 days ago
18 weeks 4 days ago
30 weeks 4 days ago
32 weeks 4 days ago
33 weeks 4 days ago